- Home
- WETH vs ATHA Comparison
WETH vs ATHA Comparison
Compare WETH & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WETH
- ATHA
- Stock Information
- Founded
- WETH 1992
- ATHA 2011
- Country
- WETH China
- ATHA United States
- Employees
- WETH N/A
- ATHA N/A
- Industry
- WETH
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- WETH
- ATHA Health Care
- Exchange
- WETH Nasdaq
- ATHA Nasdaq
- Market Cap
- WETH 10.9M
- ATHA 10.6M
- IPO Year
- WETH N/A
- ATHA 2020
- Fundamental
- Price
- WETH $0.92
- ATHA $0.34
- Analyst Decision
- WETH
- ATHA Buy
- Analyst Count
- WETH 0
- ATHA 4
- Target Price
- WETH N/A
- ATHA $11.25
- AVG Volume (30 Days)
- WETH 50.3K
- ATHA 221.9K
- Earning Date
- WETH 08-18-2025
- ATHA 07-31-2025
- Dividend Yield
- WETH N/A
- ATHA N/A
- EPS Growth
- WETH N/A
- ATHA N/A
- EPS
- WETH 0.34
- ATHA N/A
- Revenue
- WETH $41,024,264.00
- ATHA N/A
- Revenue This Year
- WETH N/A
- ATHA N/A
- Revenue Next Year
- WETH N/A
- ATHA N/A
- P/E Ratio
- WETH $2.66
- ATHA N/A
- Revenue Growth
- WETH 2.86
- ATHA N/A
- 52 Week Low
- WETH $0.76
- ATHA $0.22
- 52 Week High
- WETH $3.62
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- WETH 43.64
- ATHA 47.50
- Support Level
- WETH $0.89
- ATHA $0.29
- Resistance Level
- WETH $1.08
- ATHA $0.32
- Average True Range (ATR)
- WETH 0.08
- ATHA 0.02
- MACD
- WETH 0.00
- ATHA -0.00
- Stochastic Oscillator
- WETH 45.42
- ATHA 17.85
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.